HK6196A - Immunochemical assay for human granulocyte-macrophage colony stimulating factor - Google Patents

Immunochemical assay for human granulocyte-macrophage colony stimulating factor

Info

Publication number
HK6196A
HK6196A HK6196A HK6196A HK6196A HK 6196 A HK6196 A HK 6196A HK 6196 A HK6196 A HK 6196A HK 6196 A HK6196 A HK 6196A HK 6196 A HK6196 A HK 6196A
Authority
HK
Hong Kong
Prior art keywords
stimulating factor
colony stimulating
macrophage colony
human granulocyte
immunochemical assay
Prior art date
Application number
HK6196A
Other languages
English (en)
Inventor
John S Abrams
Dyke Robert E Van
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of HK6196A publication Critical patent/HK6196A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243Colony Stimulating Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/824Immunological separation techniques
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK6196A 1988-05-31 1996-01-11 Immunochemical assay for human granulocyte-macrophage colony stimulating factor HK6196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/201,068 US5070013A (en) 1988-05-31 1988-05-31 Immunochemical assay for human granulocyte-macrophage colony stimulating factor

Publications (1)

Publication Number Publication Date
HK6196A true HK6196A (en) 1996-01-19

Family

ID=22744353

Family Applications (1)

Application Number Title Priority Date Filing Date
HK6196A HK6196A (en) 1988-05-31 1996-01-11 Immunochemical assay for human granulocyte-macrophage colony stimulating factor

Country Status (10)

Country Link
US (1) US5070013A (ja)
EP (2) EP0344957B1 (ja)
JP (1) JPH0768277B2 (ja)
AT (1) ATE83490T1 (ja)
AU (1) AU3744289A (ja)
DE (1) DE68903882T2 (ja)
ES (1) ES2052913T3 (ja)
GR (1) GR3007000T3 (ja)
HK (1) HK6196A (ja)
WO (1) WO1989012108A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME02191B (me) * 2005-04-18 2016-02-20 Amgen Res Munich Gmbh Protutijela koja neutraliziraju ljudski čimbenik stimuliranja kolonija makrofaga
US20100255513A1 (en) * 2007-03-30 2010-10-07 Denson Lee A Serological markers of inflammatory bowel disease phenotype and disease progression
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
WO2011038467A1 (en) * 2009-10-01 2011-04-07 Csl Limited Method of treatment of philadelphia chromosome positive leukaemia
AR093297A1 (es) 2012-10-31 2015-05-27 Amgen Res (Munich) Gmbh Formulacion liquida que comprende un compuesto neutralizante de gm-csf
US9833410B2 (en) 2012-10-31 2017-12-05 Takeda Gmbh Lyophilized formulation comprising GM-CSF neutralizing compound
US10745475B2 (en) 2013-08-30 2020-08-18 Takeda Gmbh Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
WO2023110942A1 (en) * 2021-12-14 2023-06-22 Charité-Universitätsmedizin Berlin Prevention of impaired fracture healing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
DE3382317D1 (de) * 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
US4851341A (en) * 1986-12-19 1989-07-25 Immunex Corporation Immunoaffinity purification system

Also Published As

Publication number Publication date
EP0422037A1 (en) 1991-04-17
WO1989012108A1 (en) 1989-12-14
GR3007000T3 (ja) 1993-06-30
AU3744289A (en) 1990-01-05
EP0344957A1 (en) 1989-12-06
EP0344957B1 (en) 1992-12-16
DE68903882T2 (de) 1993-04-22
JPH0768277B2 (ja) 1995-07-26
JPH03502523A (ja) 1991-06-13
ATE83490T1 (de) 1993-01-15
US5070013A (en) 1991-12-03
ES2052913T3 (es) 1994-07-16
DE68903882D1 (de) 1993-01-28

Similar Documents

Publication Publication Date Title
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
AU6785987A (en) Selecting and testing antibodies for cancer therapy
AU4493685A (en) Polyclonal antibodies, preparation and use
GB8629540D0 (en) Monoclonal antibodies
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
HK6196A (en) Immunochemical assay for human granulocyte-macrophage colony stimulating factor
AU3330689A (en) Monoclonal antibodies
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
ZA898777B (en) Monoclonal antibodies
AU5444386A (en) Anti-nicotine and anti-cotinine antibodies (monoclonal and polyclonal)
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU569816B2 (en) Monoclonal anti-alpha-amylase antibody
AU616667B2 (en) Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
GB8530829D0 (en) Monoclonal antibodies
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
AU590731B2 (en) Estriol-3-sulfate protein conjugates and antibodies thereto
ZA89258B (en) Monoclonal antibodies
AU618720B2 (en) Monoclonal antibodies
GB8820036D0 (en) Monoclonal antibodies
GB2177094B (en) Diagnostic kits incorporating polyclonal antibodies.
GB2175918B (en) Monoclonal antibodies
GB8517896D0 (en) Monoclonal antibodies
ZA896085B (en) Monoclonal antibodies specific for elkenella corrodens
GB8423816D0 (en) Antibody/antigen protein
EP0336441A3 (en) Anti-cpbii monoclonal antibody